Course Overview
Diagnosing and Managing Schizophrenia: Practical Strategies for the Federal Healthcare Professional
Overview: This activity addresses important issues in the identification, diagnosis, and management of schizophrenia in patients within the federal healthcare system, which includes active-duty servicemembers, Veterans, and others. It is designed to increase the awareness of schizophrenia as a possible diagnosis among other common conditions in this patient population, assist with the development of treatment plans based on current guideline recommendations, and guide the modification of treatment regimens based on patient response, adverse effects, adherence concerns, and other treatment challenges.
|
Faculty 
Mark Olfson, MD, MPH 
William V. Bobo, MD, MPH 
Robert A. Rosenheck, MD |
Credits available: A maximum of 1.0 AMA PRA Category 1 Credit™
Types of credit available:
AMA PRA Category 1 Credit™
California Board of Registered Nursing (CBRN) 
Accreditation Council for Pharmacy Education (ACPE)
Expires: 5/25/12
This activity has been approved for AMA PRA Category 1 Credit™.
This activity is supported by
an educational grant from:
Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.
Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.
Bookmark These Med-IQ Sites
Med-IQ Specialty Sites
Med-IQ Social Media
